Madrigal Pharmaceuticals, Inc. MDGL Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s change in other assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported change in other assets of $40.65M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s change in other assets changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s change in other assets increased by 329.9% year-over-year, from $9.46M to $40.65M.
- What does change in other assets mean?
- The change in miscellaneous short-term assets.
- How do you interpret change in other assets?
- Significant changes may indicate shifts in operational strategy or timing of prepayments.
- How does change in other assets compare across companies?
- Varies widely based on company-specific accounting practices and operational needs.